Total Payments
$974,390
2024 Payments
$55,409
Companies
45
Transactions
2,461
Medicare Patients
1,261
Medicare Billing
$214,632
Payment Breakdown by Category
Other$730,796 (75.0%)
Travel$174,534 (17.9%)
Food & Beverage$50,065 (5.1%)
Consulting$18,686 (1.9%)
Education$308.49 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $661,186 | 428 | 67.9% |
| Travel and Lodging | $174,534 | 854 | 17.9% |
| Food and Beverage | $50,065 | 1,108 | 5.1% |
| Honoraria | $38,060 | 25 | 3.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $31,550 | 19 | 3.2% |
| Consulting Fee | $18,686 | 15 | 1.9% |
| Education | $308.49 | 12 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $303,649 | 589 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $174,104 | 344 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, LLC | $92,064 | 173 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $73,761 | 160 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $55,695 | 150 | $0 (2024) |
| Allergan, Inc. | $44,632 | 230 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $42,153 | 98 | $0 (2024) |
| PFIZER INC. | $32,019 | 111 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30,551 | 93 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $25,689 | 58 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,409 | 140 | Janssen Pharmaceuticals, Inc ($34,337) |
| 2023 | $82,339 | 204 | Janssen Pharmaceuticals, Inc ($38,488) |
| 2022 | $152,389 | 316 | Janssen Pharmaceuticals, Inc ($73,667) |
| 2021 | $139,451 | 359 | Paratek Pharmaceuticals, Inc. ($50,342) |
| 2020 | $110,808 | 275 | Janssen Pharmaceuticals, Inc ($47,283) |
| 2019 | $185,140 | 476 | Janssen Pharmaceuticals, Inc ($34,271) |
| 2018 | $175,857 | 462 | PORTOLA PHARMACEUTICALS, INC. ($77,148) |
| 2017 | $72,996 | 229 | Valeant Pharmaceuticals North America LLC ($23,384) |
All Payment Transactions
2,461 individual payment records from CMS Open Payments — Page 1 of 99
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,275.00 | General |
| Category: ANTIBIOTIC | ||||||
| 10/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $430.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Travel and Lodging | Cash or cash equivalent | $402.62 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Travel and Lodging | Cash or cash equivalent | $297.17 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $91.37 | General |
| Category: ANTIBIOTIC | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $132.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $33.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: ANTIBIOTIC | ||||||
| 09/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.89 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $122.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,957.50 | General |
| Category: ANTIBIOTIC | ||||||
| 09/19/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $910.00 | General |
| Category: ANTIBIOTIC | ||||||
| 09/19/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $105.24 | General |
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,553.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,105.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Travel and Lodging | Cash or cash equivalent | $567.19 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Travel and Lodging | In-kind items and services | $535.94 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $317.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Travel and Lodging | In-kind items and services | $312.48 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $56.27 | General |
| Category: ANTIBIOTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 290 | 526 | $111,498 | $47,324 |
| 2022 | 5 | 284 | 549 | $120,984 | $45,331 |
| 2021 | 7 | 350 | 698 | $148,860 | $61,105 |
| 2020 | 4 | 337 | 700 | $149,522 | $60,873 |
Total Patients
1,261
Total Services
2,473
Medicare Billing
$214,632
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 146 | 373 | $74,973 | $33,558 | 44.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 82 | 83 | $17,181 | $6,732 | 39.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $14,896 | $5,081 | 34.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 32 | $4,448 | $1,953 | 43.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 146 | 408 | $82,008 | $30,921 | 37.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 47 | $18,424 | $6,579 | 35.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 64 | 65 | $13,455 | $5,023 | 37.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $5,012 | $1,990 | 39.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 15 | $2,085 | $817.65 | 39.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 173 | 508 | $102,108 | $42,063 | 41.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 84 | 86 | $17,802 | $7,370 | 41.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 40 | 40 | $15,680 | $6,354 | 40.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $5,012 | $1,865 | 37.2% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2021 | 13 | 18 | $3,798 | $1,663 | 43.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 20 | $2,780 | $1,126 | 40.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $1,680 | $662.65 | 39.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 167 | 508 | $102,108 | $41,410 | 40.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 58 | $22,736 | $9,346 | 41.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 89 | 89 | $18,423 | $7,506 | 40.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 45 | $6,255 | $2,611 | 41.7% |
About Hameed Ali, D. O
Hameed Ali, D. O is a Internal Medicine healthcare provider based in Temple, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104974955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hameed Ali, D. O has received a total of $974,390 in payments from pharmaceutical and medical device companies, with $55,409 received in 2024. These payments were reported across 2,461 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($661,186).
As a Medicare-enrolled provider, Ali has provided services to 1,261 Medicare beneficiaries, totaling 2,473 services with total Medicare billing of $214,632. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Temple, TX
- Active Since 01/08/2007
- Last Updated 11/01/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104974955
Products in Payments
- XARELTO (Drug) $303,917
- NUZYRA (Drug) $174,104
- BEVYXXA (Drug) $77,148
- ELIQUIS (Drug) $57,350
- LifeVest (Device) $55,695
- ENTRESTO (Drug) $42,127
- TEFLARO (Drug) $39,879
- RELISTOR (Drug) $31,230
- XIFAXAN (Drug) $20,116
- Baxdela (Drug) $17,502
- DALVANCE (Drug) $17,174
- ANDEXXA (Biological) $12,795
- LOKELMA (Drug) $10,977
- DIFICID (Drug) $10,898
- ORBACTIV (Drug) $9,031
- Andexxa (Drug) $6,001
- SOLIRIS (Drug) $5,844
- AVYCAZ (Drug) $4,219
- Ultomiris (Drug) $4,027
- SAMSCA (Drug) $2,887
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Temple
Albert Hicks, M.d, M.D
Internal Medicine — Payments: $430,711
Internal Medicine $430,711
Dr. Catherine Mcneal, M.d, M.D
Internal Medicine — Payments: $191,184
Internal Medicine $191,184
Dr. Imran Siddiqui, M.d, M.D
Internal Medicine — Payments: $42,089
Internal Medicine $42,089
Dr. Ojas Vyas, M.d, M.D
Internal Medicine — Payments: $37,829
Internal Medicine $37,829
Dr. Tariq Shafi, Md, MD
Internal Medicine — Payments: $22,497
Internal Medicine $22,497
Yevgeniy Khariton, M.d, M.D
Internal Medicine — Payments: $18,885
Internal Medicine $18,885